BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 36191342)

  • 1. Clinicopathologic Impact of Peptide Hormonal Expression in Rectal Neuroendocrine Tumors.
    Kim J; Yang DH; Jung H; Cho H; Jang HJ; Yoo C; Park IJ; Ryoo BY; Ryu JS; Hong SM
    Arch Pathol Lab Med; 2023 Jul; 147(7):797-807. PubMed ID: 36191342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatostatin receptor 2 (SSTR2) expression is associated with better clinical outcome and prognosis in rectal neuroendocrine tumors.
    Kim JY; Kim J; Kim YI; Yang DH; Yoo C; Park IJ; Ryoo BY; Ryu JS; Hong SM
    Sci Rep; 2024 Feb; 14(1):4047. PubMed ID: 38374188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-L-cell immunophenotype and large tumor size in rectal neuroendocrine tumors are associated with aggressive clinical behavior and worse prognosis.
    Kim JY; Kim KS; Kim KJ; Park IJ; Lee JL; Myung SJ; Park Y; Park YS; Yu CS; Kim JC; Yu E; Jang HJ; Hong SM
    Am J Surg Pathol; 2015 May; 39(5):632-43. PubMed ID: 25724002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromogranin A Expression in Rectal Neuroendocrine Tumors Is Associated With More Aggressive Clinical Behavior and a Poorer Prognosis.
    Kim J; Kim JY; Oh EH; Yoo C; Park IJ; Yang DH; Ryoo BY; Ryu JS; Hong SM
    Am J Surg Pathol; 2020 Nov; 44(11):1496-1505. PubMed ID: 32735108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Clinicopathological Significance of Tumor Cell Subtyping in Appendiceal Neuroendocrine Tumors: A Series of 135 Tumors.
    Mete O; Dodington DW; Shen DL; Asa SL
    Endocr Pathol; 2024 Jun; 35(2):107-112. PubMed ID: 38833137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathologic and prognostic significance of multiple hormone expression in pancreatic neuroendocrine tumors.
    Kim JY; Kim MS; Kim KS; Song KB; Lee SH; Hwang DW; Kim KP; Kim HJ; Yu E; Kim SC; Jang HJ; Hong SM
    Am J Surg Pathol; 2015 May; 39(5):592-601. PubMed ID: 25602797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormonally defined pancreatic and duodenal neuroendocrine tumors differ in their transcription factor signatures: expression of ISL1, PDX1, NGN3, and CDX2.
    Hermann G; Konukiewitz B; Schmitt A; Perren A; Klöppel G
    Virchows Arch; 2011 Aug; 459(2):147-54. PubMed ID: 21739268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and functional implication of the components of somatostatin system in gastroenteropancreatic neuroendocrine tumors.
    Herrera-Martínez AD; Gahete MD; Pedraza-Arevalo S; Sánchez-Sánchez R; Ortega-Salas R; Serrano-Blanch R; Luque RM; Gálvez-Moreno MA; Castaño JP
    Endocrine; 2018 Feb; 59(2):426-437. PubMed ID: 29196939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of hormone secretory syndromes on neuroendocrine tumor prognosis.
    Zandee WT; Kamp K; van Adrichem RC; Feelders RA; de Herder WW
    Endocr Relat Cancer; 2017 Jul; 24(7):R261-R274. PubMed ID: 28483790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency and Causes of False-Positive Elevated Plasma Concentrations of Fasting Gut Hormones in a Specialist Neuroendocrine Tumor Center.
    Butler OL; Mekhael MM; Ahmed A; Cuthbertson DJ; Pritchard DM
    Front Endocrinol (Lausanne); 2020; 11():606264. PubMed ID: 33391185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rectal neuroendocrine and L-cell tumors: diagnostic dilemma and therapeutic strategy.
    Lee SH; Kim BC; Chang HJ; Sohn DK; Han KS; Hong CW; Lee EJ; Lee JB; Lee DS; Lee IT; Youk EG
    Am J Surg Pathol; 2013 Jul; 37(7):1044-52. PubMed ID: 23648459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucagon, glicentin, proglucagon, PYY, PP and proPP-icosapeptide immunoreactivities of rectal carcinoid tumors and related non-tumor cells.
    Fiocca R; Rindi G; Capella C; Grimelius L; Polak JM; Schwartz TW; Yanaihara N; Solcia E
    Regul Pept; 1987 Jan; 17(1):9-29. PubMed ID: 2882565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatostatin receptor 2 in 10 different types of human non-neoplastic gastrointestinal neuroendocrine cells.
    Watanabe H; Fujishima F; Unno M; Sasano H; Suzuki T
    Pathol Res Pract; 2023 Apr; 244():154418. PubMed ID: 36989844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphovascular invasion as a prognostic value in small rectal neuroendocrine tumor treated by local excision: A systematic review and meta-analysis.
    Kang HS; Kwon MJ; Kim TH; Han J; Ju YS
    Pathol Res Pract; 2019 Nov; 215(11):152642. PubMed ID: 31585816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The immunohistochemical expression of islet 1 and PAX8 by rectal neuroendocrine tumors should be taken into account in the differential diagnosis of metastatic neuroendocrine tumors of unknown primary origin.
    Koo J; Zhou X; Moschiano E; De Peralta-Venturina M; Mertens RB; Dhall D
    Endocr Pathol; 2013 Dec; 24(4):184-90. PubMed ID: 24037217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of novel somatostatin-dopamine chimeric drugs in 2D and 3D cell culture models of neuroendocrine tumors.
    Herrera-Martínez AD; van den Dungen R; Dogan-Oruc F; van Koetsveld PM; Culler MD; de Herder WW; Luque RM; Feelders RA; Hofland LJ
    Endocr Relat Cancer; 2019 Jun; 26(6):585-599. PubMed ID: 30939452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunostaining of gastric cancer with neuroendocrine differentiation: Reg IV-positive neuroendocrine cells are associated with gastrin, serotonin, pancreatic polypeptide and somatostatin.
    Sentani K; Oue N; Noguchi T; Sakamoto N; Matsusaki K; Yasui W
    Pathol Int; 2010 Apr; 60(4):291-7. PubMed ID: 20403031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Somatostatin Signalling in Neuroendocrine Tumours.
    Rogoza O; Megnis K; Kudrjavceva M; Gerina-Berzina A; Rovite V
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Excellent prognosis following endoscopic resection of patients with rectal neuroendocrine tumors despite the frequent presence of lymphovascular invasion.
    Sekiguchi M; Sekine S; Sakamoto T; Otake Y; Nakajima T; Matsuda T; Taniguchi H; Kushima R; Ohe Y; Saito Y
    J Gastroenterol; 2015 Dec; 50(12):1184-9. PubMed ID: 25936647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of somatostatins in gastroenteropancreatic neuroendocrine tumor development and therapy.
    Oberg KE; Reubi JC; Kwekkeboom DJ; Krenning EP
    Gastroenterology; 2010 Sep; 139(3):742-53, 753.e1. PubMed ID: 20637207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.